
51 - 200 employees
Founded 2020
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
Healthcare • Consulting • Manufacturing
BigHat Biosciences is a biotechnology company focused on designing safer, more effective antibody therapies using machine learning and synthetic biology. The company leverages its Milliner platform, which integrates a high-speed wet lab with state-of-the-art machine learning technologies, to discover and engineer antibodies for intractable diseases like infections and cancers. Their approach promises to deliver next-generation therapies with improved safety and efficacy. Based outside San Francisco, BigHat Biosciences engages in strategic collaborations and partnerships to enhance their therapeutic programs and has raised significant funding to pursue these innovative solutions.
🔥 2 hours ago
Principal ML Scientist advancing BigHat Biosciences’ machine-learning antibody drug design platform. Developing generative and predictive models, optimizing protein sequences, and supporting accelerated therapeutic development.